Zobrazeno 1 - 10
of 10
pro vyhledávání: '"José Hernandez-Quero"'
Autor:
Alejandro Gonzalez-Serna, Juan Macias, Anaïs Corma-Gomez, Francisco Tellez, Josep Cucurull, Luis M Real, Rafael Granados, Antonio Rivero-Juarez, José Hernandez-Quero, Dolores Merino, Rosario Palacios, Maria José Rios, Antonio Collado, Juan A. Pineda
[Objectives] Real world data on glecaprevir/pibrentasvir (G/P) among active drug users are scarce. We evaluated the sustained virological response (SVR) rates of G/P among individuals with and without active drug use in routine clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4145159ea357f22df2e834c06d25aabf
http://hdl.handle.net/10261/306129
http://hdl.handle.net/10261/306129
Autor:
José Ramón Santos, Maria Casadellà, Marc Noguera-Julian, Rafael Micán-Rivera, Pere Domingo, Antonio Antela, Joaquin Portilla, Jesús Sanz, Marta Montero-Alonso, Jordi Navarro, Mar Masiá, Nieves Valcarce-Pardeiro, Antonio Ocampo, Laura Pérez-Martínez, Coral García-Vallecillos, María Jesús Vivancos, Arkaitz Imaz, José Antonio Iribarren, José Hernández-Quero, Judit Villar-García, Pilar Barrufet, Roger Paredes, INSTINCT study group, Mariona Perera, Anna Chamorro, Cristina Miranda, Nástor Sánchez, Anna Garcı́á, Núria Pérez, Juan González Garcı́á, María del Mar Gutiérrez, María Gracia Mateo, Elena Losada, Sergio Reus, Vicente Boix, Diego Torrús, Esperanza Merino, Angela Gutiérrez Liarte, Adrià Curran, Félix Gutiérrez, Anna Mariño Callejo, Alvarez Diaz Hortensia, Antonio Ocampo Hermida, Celia Miralles, Laura Labajo Leal, Guillermo Pousada, José Ramon Blanco, José Antonio Oteo, Ibarra Valvanera, Mercedes Sanz, Luis Metola, Juan Pascua, Daniel Podzamczer, Camila Piatti, Maialen Ibarguren, Laia Arbones, Marta Ruiz, Sara Cervanntes, Helena Pera, Jessica Toro, Nuria Perez-Alvarez, Anna Garcia
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionSecond-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings. Nevertheless, in some resource-limited settings, th
Externí odkaz:
https://doaj.org/article/63e60100a5744c33a4e4d6da36790d78
Autor:
María Ángeles Rodríguez-Hernández, David Carneros, María Núñez-Núñez, Ramón Coca, Rosario Baena, Gema M. López-Ruiz, María Elena Cano-Serrano, Alberto Martínez-Tellería, Ana Fuentes-López, Juan Manuel Praena-Fernandez, Christoph Garbers, José Hernández-Quero, Federico García, Stefan Rose-John, Matilde Bustos
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IL-6 is one of the major mediators of the hyper-inflammatory responses with complex biological functions as it can signal via different modes of action. IL-6 by classical signalling has anti-inflammatory and antibacterial activities, while trans-sign
Externí odkaz:
https://doaj.org/article/b07818f2d1a947b48b1f02af608a5c72
Autor:
Anita Y.M. Howe, Chaturaka Rodrigo, Evan B. Cunningham, Mark W. Douglas, Julia Dietz, Jason Grebely, Stephanie Popping, Javier Alejandro Sfalcin, Milosz Parczewski, Christoph Sarrazin, Adolfo de Salazar, Ana Fuentes, Murat Sayan, Josep Quer, Midori Kjellin, Hege Kileng, Orna Mor, Johan Lennerstrand, Slim Fourati, Velia Chiara Di Maio, Vladimir Chulanov, Jean-Michel Pawlotsky, P. Richard Harrigan, Francesca Ceccherini-Silberstein, Federico Garcia, Marianne Martinello, Gail Matthews, Fay Fabián Fernando, Juan I. Esteban, Beat Müllhaupt, Julian Schulze zur Wiesch, Peter Buggisch, Christoph Neumann-Haefelin, Thomas Berg, Christoph P. Berg, Jörn M. Schattenberg, Christophe Moreno, Rudolf Stauber, Andrew Lloyd, Gregory Dore, Tanya Applegate, Juan Ignacio, Damir Garcia-Cehic, Josep Gregori, Francisco Rodriguez-Frias, Ariadna Rando, Yael Gozlan, Mario Angelico, Massimo Andreoni, Sergio Babudieri, Ada Bertoli, Valeria Cento, Nicola Coppola, Antonio Craxì, Stefania Paolucci, Giustino Parruti, Caterina Pasquazzi, Carlo Federico Perno, Elisabetta Teti, C. Vironet, Anders Lannergård, Ann-Sofi Duberg, Soo Aleman, Tore Gutteberg, Alexandre Soulier, Aurélie Gourgeon, Stephane Chevaliez, Stanislas Pol, Fabrice Carrat, Dominique Salmon, Rolf Kaiser, Elena Knopes, Perpetua Gomes, Rob de Kneght, Bart Rijnders, Mario Poljak, Maja Lunar, Rafael Usubillaga, Carole Seguin_Devaux, Enoch Tay, Caroline Wilson, Dao Sen Wang, Jacob George, Jen Kok, Ana Belén Pérez, Natalia Chueca, Miguel García-Deltoro, Ana María Martínez-Sapiña, María Magdalena Lara-Pérez, Silvia García-Bujalance, Teresa Aldámiz-Echevarría, Francisco Jesús Vera-Méndez, Juan Antonio Pineda, Marta Casado, Juan Manuel Pascasio, Javier Salmerón, Juan Carlos Alados-Arboledas, Antonio Poyato, Francisco Téllez, Antonio Rivero-Juárez, Dolores Merino, María Jesús Vivancos-Gallego, José Miguel Rosales-Zábal, María Dolores Ocete, Miguel Ángel Simón, Pilar Rincón, Sergi Reus, Alberto De la Iglesia, Isabel García-Arata, Miguel Jiménez, Fernando Jiménez, José Hernández-Quero, Carlos Galera, Mohamed Omar Balghata, Joaquín Primo, Mar Masiá, Nuria Espinosa, Marcial Delgado, Miguel Ángel von-Wichmann, Antonio Collado, Jesús Santos, Carlos Mínguez, Felícitas Díaz-Flores, Elisa Fernández, Enrique Bernal, José De Juan, José Joaquín Antón, Mónica Vélez, Antonio Aguilera, Daniel Navarro, Juan Ignacio Arenas, Clotilde Fernández, María Dolores Espinosa, María José Ríos, Roberto Alonso, Carmen Hidalgo, Rosario Hernández, María Jesús Téllez, Francisco Javier Rodríguez, Pedro Antequera, Cristina Delgado, Patricia Martín, Javier Crespo, Berta Becerril, Oscar Pérez, Antonio García-Herola, José Montero, Carolina Freyre, Concepción Grau, Joaquin Cabezas, Miguel Jimenez, Manuel Alberto Macias Rodriguez, Cristina Quilez, Maria Rodriguez Pardo, Leopoldo Muñoz-Medina, Blanca Figueruela
Publikováno v:
JHEP Reports, Vol 4, Iss 5, Pp 100462- (2022)
Background & Aims: Direct-acting antiviral (DAA) regimens provide a cure in >95% of patients with chronic HCV infection. However, in some patients in whom therapy fails, resistance-associated substitutions (RASs) can develop, limiting retreatment opt
Externí odkaz:
https://doaj.org/article/f2e6a1ce74794d3c98e6f58a4144688c
Autor:
Ana Belén Pérez, Natalia Chueca, Juan Macías, Juan Antonio Pineda, Javier Salmerón, Antonio Rivero-Juárez, Carmen Hidalgo-Tenorio, María Dolores Espinosa, Francisco Téllez, Miguel Ángel Von-Wichmann, Mohamed Omar, Jesús Santos, José Hernández-Quero, José Joaquin Antón, Antonio Collado, Ana Belén Lozano, Miguel García-Deltoro, Marta Casado, Juan Manuel Pascasio, Aida Selfa, José Miguel Rosales, Alberto De la Iglesia, Juan Ignacio Arenas, Silvia García-Bujalance, María José Ríos, Enrique Bernal, Onofre Martínez, Antonio García-Herola, Mónica Vélez, Pilar Rincón, Federico García
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221231 (2019)
Treatment guidelines differ in their recommendation to determine baseline resistance associated substitutions (RAS) before starting a first-line treatment with direct-acting antivirals (DAAs). Here we analyze the efficacy of DAA treatment with baseli
Externí odkaz:
https://doaj.org/article/772af61f55174fca9fb2de6905d5ba87
Autor:
Beatriz Dominguez-Molina, Sara Ferrando-Martinez, Laura Tarancon-Diez, Jose Hernandez-Quero, Miguel Genebat, Francisco Vidal, Mª Angeles Muñoz-Fernandez, Manuel Leal, Richard Koup, Ezequiel Ruiz-Mateos
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
HIV-elite controllers are a minority group of HIV-infected patients with the ability to maintain undetectable HIV viremia for long time periods without antiretroviral treatment. A small group of HIV-controllers are also able to spontaneously clear th
Externí odkaz:
https://doaj.org/article/bc2a61a8cc024e6199ae59477760f4af
Autor:
Juan Pasquau, Carmen Hidalgo-Tenorio, María Luisa Montes, Alberto Romero-Palacios, Jorge Vergas, Isabel Sanjoaquín, José Hernández-Quero, Koldo Aguirrebengoa, Francisco Orihuela, Arkaitz Imaz, María José Ríos-Villegas, Juan Flores, María Carmen Fariñas, Pilar Vázquez, María José Galindo, Isabel García-Mercé, Fernando Lozano, Ignacio de Los Santos, Samantha Elizabeth de Jesus, Coral García-Vallecillos, QoLKAMON STUDY GROUP
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195068 (2018)
The QoLKAMON study evaluated quality of life, efficacy and treatment safety in HIV patients receiving lopinavir/ritonavir in monotherapy (MT) versus continuing combined antiretroviral triple treatment with a boosted protease inhibitor (TT).This was a
Externí odkaz:
https://doaj.org/article/8868e0011443414a95d5d2a1311688f6
Autor:
Karin Neukam, Nuria Espinosa, Antonio Collado, Marcial Delgado-Fernández, Patricia Jiménez-Aguilar, Antonio Rivero-Juárez, Victor Hontañón-Antoñana, Ana Gómez-Berrocal, Josefa Ruiz-Morales, Dolores Merino, Ana Carrero, Francisco Téllez, María José Ríos, José Hernández-Quero, María de Lagarde-Sebastián, Inés Pérez-Camacho, Francisco Vera-Méndez, Juan Macías, Juan A Pineda, hEPAtic Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155842 (2016)
OBJECTIVES:The aim of this study was to evaluate the frequency of transaminase elevations (TE) and total bilirubin elevations (TBE) during the first year of therapy with a single tablet regimen including RPV/FTC/TDF (EPA) in HIV/hepatitis C virus (HC
Externí odkaz:
https://doaj.org/article/8dfd43ec69cd4a9b9c8f7ff5b2fb7c1b
Autor:
Luis F López-Cortés, Manuel A Castaño, Miguel A López-Ruz, María J Rios-Villegas, José Hernández-Quero, Dolores Merino, Patricia Jiménez-Aguilar, Manuel Marquez-Solero, Alberto Terrón-Pernía, Francisco Tellez-Pérez, Pompeyo Viciana, Francisco Orihuela-Cañadas, Zaira Palacios-Baena, David Vinuesa-Garcia, Jose M Fajardo-Pico, Alberto Romero-Palacios, Guillermo Ojeda-Burgos, Juan Pasquau-Liaño
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148924 (2016)
BACKGROUND AND OBJECTIVE:Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failu
Externí odkaz:
https://doaj.org/article/68978ecd16e8457abeccfd431b980b4a
Autor:
Juan D Unciti-Broceta, José L Arias, José Maceira, Miguel Soriano, Matilde Ortiz-González, José Hernández-Quero, Manuel Muñóz-Torres, Harry P de Koning, Stefan Magez, José A Garcia-Salcedo
Publikováno v:
PLoS Pathogens, Vol 11, Iss 6, p e1004942 (2015)
African trypanosomiasis is a deadly neglected disease caused by the extracellular parasite Trypanosoma brucei. Current therapies are characterized by high drug toxicity and increasing drug resistance mainly associated with loss-of-function mutations
Externí odkaz:
https://doaj.org/article/62cf768c8f2b4d82a0cdb7aa2efb57a9